Name: Haoxi Health Technology Limited (HAO) Financial Statements
Creator: FinSpry

Haoxi Health Technology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Haoxi Health Technology Limited income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Revenue & Gross Profit
Revenue	32.80	48.52	28.23	16.16	12.85
Cost of Revenue	31.88	45.77	26.17	15.51	12.24
Gross Profit	0.93	2.75	2.06	0.65	0.61
Operating Expenses
Research & Development	0.08	0.08	0.06	0.10	0.06
Selling, General & Administrative	2.85	0.95	0.81	0.28	0.21
Operating Expenses	2.93	1.03	0.87	0.38	0.28
Operating Income	-2.00	1.72	1.20	0.27	0.33
Other Income/Expense
Interest Income	0.36	0.08	0.00	0.00	0.00
Interest Expense	0.05	-0.04	0.02	-0.01	0.00
Other Income/Expense	6.15	0.02	0.02	0.00	0.00
Income
Income Before Tax	4.15	1.74	1.19	0.26	0.33
Income Tax Expense	0.27	0.44	0.22	0.02	0.02
Net Income	3.88	1.29	0.97	0.24	0.30
Net Income - Continuous Operations	3.88	1.29	0.97	0.24	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	4.57	1.79	1.22	0.27	0.33
EBIT	-2.00	1.78	1.21	0.27	0.33
Depreciation & Amortization	0.37	0.01	0.01	0.00	0.00
Earnings Per Share
Basic EPS	2.00	-	1.00	-	-
Diluted EPS	1.00	-	1.00	-	-
Basic Shares Outstanding	2.33	30.60	1.10	1.00	1.00
Diluted Shares Outstanding	2.40	30.60	1.75	1.00	1.00